- My News
- All News
- Most Popular
Expandable platform integrates EchoNous' current intelligent tools, aimed at raising convenience for nurses.
PITTSBURGH--(BUSINESS WIRE)-- EchoNous, a developer of intelligent medical tools, is applying the emerging field of artificial intelligence (AI) with the extreme miniaturization of ultrasound to solve common everyday problems in health care. During Emergency Nursing 2018 September 26-29 in Pittsburgh, EchoNous will be providing nurses hands-on demonstrations of the EchoNous Vein, a best-in-class tool designed to improve first-time peripheral IV (PIV) placement. Of particular importance in emergency medicine, using ultrasound guidance for peripheral IVs can expedite treatment in an ED and positively impact patient satisfaction1, including HCAHPS scoring. EchoNous Vein rivals performance of much larger ultrasound systems at 50% lower cost to health systems.
"We know from our experience that ED nurses are often inundated with clinical demands for speed and accuracy, while being challenged by a higher number of patients who present with difficult vascular access, not to mention HCAHPS," said Kevin Goodwin, CEO of EchoNous. "We designed our EchoNous Vein to quickly and easily access veins to assist nurses in placing IVs, a fundamental step in emergency medical care, while also saving health systems money."
Nurses attending the conference will also see the company's recently released AI Station, a docking system that brings together the all tools needed for bladder scanning, vascular access, and in the future more intelligent medical tools.
More information on how EchoNous Vein aims to improve patient satisfaction is available in the short video EchoNous Vein - Ultrasound guidance designed for peripheral IV placement. Nurses attending Emergency Nursing 2018 are invited to learn more about EchoNous' intelligent medical tools by visiting Booth #1129 during the conference.
1 Moore, Cindi. "An Emergency Department Nurse-Driven Ultrasound-Guided Peripheral Intravenous Line Program." Journal of the Association for Vascular Access; 18 (1), 2013: 45-51.
Headquartered in Seattle, Washington, EchoNous, a KKR portfolio company and parent company of Signostics, is developing an expanding family of intelligent medical tools to help healthcare professionals solve common everyday problems in healthcare. Beginning with the EchoNous Vein vascular access tool and the Uscan intelligent bladder scanner, EchoNous is applying a layer of artificial intelligence to extreme miniaturized ultrasound to provide nurses, doctors and clinicians with high-quality, easy-to-use tools simplifying the task at hand. CEO and industry innovator Kevin Goodwin and EVP, COO & CIO Niko Pagoulatos, PhD, a prolific engineering leader, together direct the company based on decades of successful experience and new category creation in the ultrasound industry. For more information, visit www.echonous.com.
Signostics and Uscan are Trademarks of Signostics Limited.
Caution: Federal (USA) law restricts this device to sale by or on the order of a physician.
View source version on businesswire.com: https://www.businesswire.com/news/home/20180926005790/en/
View this news release online at:
Did you like this article?